País: Irlanda
Língua: inglês
Origem: HPRA (Health Products Regulatory Authority)
IVERMECTIN, CLOSANTEL (AS CLOSANTEL SODIUM DIHYDRATE PH. EUR.)
Norbrook Laboratories Limited
QP54AA51
IVERMECTIN, CLOSANTEL (AS CLOSANTEL SODIUM DIHYDRATE PH. EUR.)
0.5/20
Pour-on Solution
LM-Licensed Merchant
Bovine
Ivermectin, combinations
Endectoparasiticides
Authorised
2012-05-25
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Closivet Pour-On Solution for Cattle 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Ivermectin 5 mg Closantel (as closantel sodium) 200 mg EXCIPIENTS Brilliant Blue FCF (E133) 0.1 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Pour-On solution. A clear blue/green solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 16/11/2016_ _CRN 7024742_ _page number: 1_ 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of mixed trematode (fluke) and nematode or arthropod infestations due to roundworms, lungworms, eyeworms, warbles, mites and lice of cattle. Gastrointestinal roundworms (adults and fourth stage larvae) _Ostertagia ostertagi _(including inhibited _O. ostertagi_), _Haemonchus placei, Trichostrongylus axei, Trichostrongylus_ _colubriformis, Cooperia _spp, _Oesophagostomum radiatum, Nematodirus helvetianus _(adult), _Strongyloides papillosus _(adult). Lungworms (adult and fourth stage larvae) _Dictyocaulus viviparus_ Trematodes (adult and late immatures) _Fasciola gigantica_ _Fasciola hepatica_ Treatment of fluke at 12 weeks (mature) >95% efficacy. Treatment of fluke at 7 weeks (late immature) >95% efficacy. Eyeworms (adult) _Thelazia _spp Cattle grubs (parasitic stages) _Hypoderma bovis, Hypoderma lineatum_ Lice _Linognathus vituli, Haematopinus eurysternus, Damalinia bovis_ Mange Mites _Chorioptes bovis, Sarcoptes scabiei var b_ovis 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to the active substances. Do not apply to areas of skin which have mange, scabs or other lesions or to areas c Leia o documento completo